Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.31 +0.10 (+1.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Total Debt (2022 - 2024)

Updated

Eupraxia Pharmaceuticals' Total Debt was $21,209 in the quarter ended Jun 30, 2024, down 49.6% from the prior quarter.

Analysis

Eupraxia Pharmaceuticals (EPRX) Total Debt (2022 - 2024) Analysis & Trends

As of Dec 31, 2023, Total Debt at Eupraxia Pharmaceuticals came in at $62,709, down 55.9% from the prior year.

  • In earlier years, Total Debt was $142,127 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Eupraxia Pharmaceuticals 328.04 Mn 326.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 21,209.00
Mar 31, 2024 42,112.00
Dec 31, 2023 62,709.00
Dec 31, 2022 142,127.00
API Access

Eupraxia Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=EPRX&period=max&api_key=YOUR_API_KEY